|
1.
|
|
9 p, 1.5 MB |
Circulating metabolomic profile can predict dyslipidemia in HIV patients undergoing antiretroviral therapy
/
Rodríguez-Gallego, Esther (Hospital Universitari Joan XXIII de Tarragona) ;
Gómez, Josep (Universitat Rovira i Virgili) ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
Ferrando-Martínez, Sara (National Institutes of Health (NIH)) ;
Peraire, Joaquim (Hospital Universitari Joan XXIII de Tarragona) ;
Viladés, Consuelo (Hospital Universitari Joan XXIII de Tarragona) ;
Veloso, Sergi (Hospital Universitari Joan XXIII de Tarragona) ;
López-Dupla, Miguel (Hospital Universitari Joan XXIII de Tarragona) ;
Beltrán-Debón, Raúl (Hospital Universitari Joan XXIII de Tarragona) ;
Alba, Verónica (Hospital Universitari Joan XXIII de Tarragona) ;
Vargas, Montserrat (Hospital Universitari Joan XXIII de Tarragona) ;
Castellano, Alfonso J. (Hospital Universitari Joan XXIII de Tarragona) ;
Leal, Manuel (Universidad de Sevilla) ;
Pacheco, Yolanda María (Universidad de Sevilla) ;
Ruiz-Mateos, Ezequiel (Universidad de Sevilla) ;
Gutiérrez, Félix (Hospital General de Elche y Universidad Miguel Hernández) ;
Vidal, Francesc (Hospital Universitari Joan XXIII de Tarragona) ;
Rull, Anna (Hospital Universitari Joan XXIII de Tarragona) ;
Universitat Autònoma de Barcelona
Dyslipidemia in HIV-infected patients is unique and pathophysiologically associated with host factors, HIV itself and the use of antiretroviral therapy (ART). The use of nuclear magnetic resonance spectroscopy (NMR) provides additional data to conventional lipid measurements concerning the number of lipoprotein subclasses and particle sizes. [...]
2018 -  10.1016/j.atherosclerosis.2018.04.008
Atherosclerosis, Vol. 273 (june 2018) , p. 28-36
|
|
|
2.
|
|
0 p, 509.1 KB |
First-Trimester Sequential Screening for Preeclampsia Using Angiogenic Factors : Study Protocol for a Prospective, Multicenter, Real Clinical Setting Study
/
Trilla, Cristina (Institut d'Investigació Biomèdica Sant Pau) ;
Luna, Cristina (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ;
De León Socorro, Silvia (Complejo Hospitalario Universitario Insular) ;
Rodriguez, Leire (Osakidetza) ;
Ruiz-Romero, Aina (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ;
Mora Brugués, Josefina (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Benítez Delgado, Taysa (Complejo Hospitalario Universitario Insular) ;
Fabre, Marta (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ;
Martin Martínez, Alicia (Complejo Hospitalario Universitario Insular) ;
Ruiz-Martinez, Sara (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ;
Llurba, E (Institut d'Investigació Biomèdica Sant Pau) ;
Oros, Daniel (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ;
Universitat Autònoma de Barcelona
The incidence of preeclampsia (PE) is about 2-8%, making it one of the leading causes of perinatal morbidity and maternal mortality in the world. Early prophylactic low dose administration (150 mg) of acetylsalicylic acid is associated with a significant reduction in the incidence of early-onset PE, intrauterine growth restriction (IUGR), and neonatal mean stay in the intensive care unit (ICU). [...]
2022 - 10.3389/fcvm.2022.931943
Frontiers in Cardiovascular Medicine, Vol. 9 (july 2022)
|
|
|
3.
|
|
11 p, 358.5 KB |
Trends in the epidemiology of catheter-related bloodstream infections; towards a paradigm shift, Spain, 2007 to 2019
/
Badia-Cebada, Laia (Universitat Autònoma de Barcelona. Facultat de Medicina) ;
Peñafiel, Judit (Unit of Statistics. Hospital Universitari de Bellvitge. Institut d'Investigació Biomèdica de Bellvitge-IDIBELL) ;
Saliba, Patrick (VINCat Programme. Infection Control Catalan Programme) ;
Andrés, Marta (Infectious Diseases Unit, Department of Internal Medicine, Hospital Consorci de Terrassa, Spain) ;
Càmara, Jordi (CIBER de Enfermedades Respiratorias (CIBERes). ISCIII) ;
Domènech, Dolors (Hospital Universitari de Girona Doctor Josep Trueta) ;
Jiménez-Martínez, Emili (Institut d'Investigació Biomèdica de Bellvitge) ;
Marrón, Anna (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Moreno, Encarna (Infection Control Nurse, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain) ;
Pomar, Virginia (Institut d'Investigació Biomèdica Sant Pau) ;
Vaqué, Montserrat (Infection Control Nurse, Hospital de Barcelona, Barcelona) ;
Limón, Enric (VINCat Programme. Infection Control Catalan Programme) ;
Masats, Úrsula (Infection Control Nurse. Hospital Universitari Mútua Terrassa) ;
Pujol, Miquel (Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat) ;
Gasch Blasi, Oriol (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Jover, Alfredo (VINCat programme-Infection Control Catalan Programme) ;
Castellana, Dolors (VINCat programme-Infection Control Catalan Programme) ;
Olona, Montserrat (VINCat programme-Infection Control Catalan Programme) ;
García Pino, Antonia (VINCat programme-Infection Control Catalan Programme) ;
Rebull Fatsini, Josep (VINCat programme-Infection Control Catalan Programme) ;
Domènech, Mª France (VINCat programme-Infection Control Catalan Programme) ;
Pujol, Miquel (VINCat programme-Infection Control Catalan Programme) ;
Hornero, Ana (VINCat programme-Infection Control Catalan Programme) ;
Ardanuy Tisaire, Carmen (VINCat programme-Infection Control Catalan Programme) ;
Berbel Palau, Dàmaris (VINCat programme-Infection Control Catalan Programme) ;
López-Contreras, Joaquín (VINCat programme-Infection Control Catalan Programme) ;
Fernández, Engracia (VINCat programme-Infection Control Catalan Programme) ;
Salgado, Xavier (VINCat programme-Infection Control Catalan Programme) ;
Lérida, Ana (VINCat programme-Infection Control Catalan Programme) ;
Martin, Lydia (VINCat programme-Infection Control Catalan Programme) ;
Sopena, Nieves (VINCat programme-Infection Control Catalan Programme) ;
Casas García, Irma (VINCat programme-Infection Control Catalan Programme) ;
Pérez, Rafael (VINCat programme-Infection Control Catalan Programme) ;
Maraver, Encarna (VINCat programme-Infection Control Catalan Programme) ;
Palau, Eva (VINCat programme-Infection Control Catalan Programme) ;
Serrats, Pepi (VINCat programme-Infection Control Catalan Programme) ;
Martínez, José Antonio (VINCat programme-Infection Control Catalan Programme) ;
Santana, Gemina (VINCat programme-Infection Control Catalan Programme) ;
Martínez, Ana (VINCat programme-Infection Control Catalan Programme) ;
Ferrer, Lourdes (VINCat programme-Infection Control Catalan Programme) ;
Moreno, Mª José (VINCat programme-Infection Control Catalan Programme) ;
Calbo Sebastián, Esther (VINCat programme-Infection Control Catalan Programme) ;
Porta, Carolina (VINCat programme-Infection Control Catalan Programme) ;
Smithson, Alex (VINCat programme-Infection Control Catalan Programme) ;
de la Roca Toda, Maria (VINCat programme-Infection Control Catalan Programme) ;
Aliu, Teresa (VINCat programme-Infection Control Catalan Programme) ;
Camps, Susana (VINCat programme-Infection Control Catalan Programme) ;
Ortega, Montserrat (VINCat programme-Infection Control Catalan Programme) ;
Diaz-Brito, Vicens (VINCat programme-Infection Control Catalan Programme) ;
Moreno, Encarna (VINCat programme-Infection Control Catalan Programme) ;
Agusti, Carme (VINCat programme-Infection Control Catalan Programme) ;
Perea Garcia, Miquel (VINCat programme-Infection Control Catalan Programme) ;
Andrés, Marta (VINCat programme-Infection Control Catalan Programme) ;
Grau Palafox, Laura (VINCat programme-Infection Control Catalan Programme) ;
Carrera, Raquel (VINCat programme-Infection Control Catalan Programme) ;
Besolí, Anna (VINCat programme-Infection Control Catalan Programme) ;
Horcajada, Juan Pablo (VINCat programme-Infection Control Catalan Programme) ;
Gonzalez, Cristina (VINCat programme-Infection Control Catalan Programme) ;
Cuquet, Jordi (VINCat programme-Infection Control Catalan Programme) ;
Maldonado López, Demelsa Maria (VINCat programme-Infection Control Catalan Programme) ;
Benítez, Rosa (VINCat programme-Infection Control Catalan Programme) ;
Duch, Mireia (VINCat programme-Infection Control Catalan Programme) ;
Blancas, David (VINCat programme-Infection Control Catalan Programme) ;
Moreno, Esther (VINCat programme-Infection Control Catalan Programme) ;
Villalba, Naiara (VINCat programme-Infection Control Catalan Programme) ;
Martínez, Sara (VINCat programme-Infection Control Catalan Programme) ;
García Flores, Àngels (VINCat programme-Infection Control Catalan Programme) ;
Ferrer, Roser (VINCat programme-Infection Control Catalan Programme) ;
Bisbe, Josep (VINCat programme-Infection Control Catalan Programme) ;
Blascó, Montse (VINCat programme-Infection Control Catalan Programme) ;
Castro Salom, Antoni (VINCat programme-Infection Control Catalan Programme) ;
López, Ana Felisa (VINCat programme-Infection Control Catalan Programme) ;
Espinach Alvarós, Joan (VINCat programme-Infection Control Catalan Programme) ;
Perez, Àngels (VINCat programme-Infection Control Catalan Programme) ;
Castander, David (VINCat programme-Infection Control Catalan Programme) ;
Calaf, Elisabet (VINCat programme-Infection Control Catalan Programme) ;
Clarós, Mercè (VINCat programme-Infection Control Catalan Programme) ;
Bosch Ros, Núria (VINCat programme-Infection Control Catalan Programme) ;
Montardit, Irene (VINCat programme-Infection Control Catalan Programme) ;
Porta, Roser (VINCat programme-Infection Control Catalan Programme) ;
De la Cruz Sol, Pilar (VINCat programme-Infection Control Catalan Programme) ;
Coll Colell, Mª Rosa (VINCat programme-Infection Control Catalan Programme) ;
García Penche Sanches, Rosa (VINCat programme-Infection Control Catalan Programme) ;
Tricas, Josep Maria (VINCat programme-Infection Control Catalan Programme) ;
Redon, Eva (VINCat programme-Infection Control Catalan Programme) ;
Brugués, Montse (VINCat programme-Infection Control Catalan Programme) ;
Linares, Laura (VINCat programme-Infection Control Catalan Programme) ;
Cusco, Maria (VINCat programme-Infection Control Catalan Programme) ;
Barrufet, Mª Pilar (VINCat programme-Infection Control Catalan Programme) ;
Vidal, Elena (VINCat programme-Infection Control Catalan Programme) ;
Barbadillo, Sandra (VINCat programme-Infection Control Catalan Programme) ;
Marimón, Mariló (VINCat programme-Infection Control Catalan Programme) ;
Meije, Yolanda (VINCat programme-Infection Control Catalan Programme) ;
Vaqué, Montserrat (VINCat programme-Infection Control Catalan Programme) ;
Laplace Enguinados, M.Rosa (VINCat programme-Infection Control Catalan Programme) ;
Vila, Blanca (VINCat programme-Infection Control Catalan Programme) ;
Coloma, Ana Guadalupe (VINCat programme-Infection Control Catalan Programme) ;
López, Lucrecia (VINCat programme-Infection Control Catalan Programme) ;
Campins Martí, Magda (VINCat programme-Infection Control Catalan Programme) ;
Almirante Gragera, Benito (VINCat programme-Infection Control Catalan Programme) ;
Ferrer, Carme (VINCat programme-Infection Control Catalan Programme) ;
Juan Serra, Natalia (VINCat programme-Infection Control Catalan Programme) ;
Farguell Carrera, Josep (VINCat programme-Infection Control Catalan Programme) ;
Garcia Flores, Àngels (VINCat programme-Infection Control Catalan Programme) ;
Ferrer, Roser (VINCat programme-Infection Control Catalan Programme) ;
Milian Sanz, Marta (VINCat programme-Infection Control Catalan Programme) ;
Moise, Alexandra (VINCat programme-Infection Control Catalan Programme) ;
Jiménez Zarate, Ana Mª (VINCat programme-Infection Control Catalan Programme) ;
Eito Navasal, M. Carmen (VINCat programme-Infection Control Catalan Programme) ;
Garcia Ramirez, María Gracia (VINCat programme-Infection Control Catalan Programme) ;
Armario Fernández, Mar (VINCat programme-Infection Control Catalan Programme) ;
Universitat Autònoma de Barcelona
Background: Catheter-related bloodstream infections (CRBSI) are frequent healthcare-associated infections and an important cause of death. Aim: To analyse changes in CRBSI epidemiology observed by the Infection Control Catalan Programme (VINCat). [...]
2022 - 10.2807/1560-7917.ES.2022.27.19.2100610
Eurosurveillance, Vol. 27 Núm. 19 (december 2022) , p. 2100610
|
|
|
4.
|
|
18 p, 30.1 MB |
Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton's Jelly Mesenchymal Stromal Cells : Proof of Concept and Regulatory Compliance
/
Vives Armengol, Joaquim (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Hernández, Joaquim (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Mirabel, Clémentine (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Puigdomenech-poch, Maria (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Romeo-Guitart, David (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Marmolejo Martínez-Artesero, Sara (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Cabrera-Pérez, Raquel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Jaramillo, Jessica (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Kumru, Hatice (Universitat Autònoma de Barcelona. Departament de Medicina) ;
García-lópez, Joan (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Vidal-Samsó, Joan (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Navarro, X. (Xavier) (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Coll-Bonet, Ruth (Banc de Sang i Teixits)
(1) Background: the use of Mesenchymal Stromal Cells (MSC) in emerging therapies for spinal cord injury (SCI) hold the potential to improve functional recovery. However, the development of cell-based medicines is challenging and preclinical studies addressing quality, safety and efficacy must be conducted prior to clinical testing; (2) Methods: herein we present (i) the characterization of the quality attributes of MSC from the Wharton's jelly (WJ) of the umbilical cord, (ii) safety of intrathecal infusion in a 3-month subchronic toxicity assessment study, and (iii) efficacy in a rat SCI model by controlled impaction (100 kdynes) after single (day 7 post-injury) and repeated dose of 1 × 10 MSC,WJ (days 7 and 14 post-injury) with 70-day monitoring by electrophysiological testing, motor function assessment and histology evaluation; (3) Results: no toxicity associated to MSC,WJ infusion was observed. [...]
2022 - 10.3390/cells11142153
Cells, Vol. 11 Núm. 14 (7-2 2022) , p. 2153
|
|
|
5.
|
|
14 p, 710.8 KB |
Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life
/
Carol, Marta (Universitat de Barcelona) ;
Pérez-Guasch, Martina (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Solà, Elsa (Universitat de Barcelona) ;
Cervera, Marta (Universitat de Barcelona) ;
Martínez, Sara (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Juanola, Adrià (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Ma, Ann T. (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Avitabile, Emma (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Napoleone, Laura (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Pose, Elisa (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Graupera, Isabel (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Honrubia Pérez, María (Universitat de Barcelona) ;
Korenjak, Marko (European Liver Patients Association (Bèlgica)) ;
Torres, Ferran (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ;
Ginès, Pere (Universitat de Barcelona) ;
Fabrellas, Núria (Universitat de Barcelona. Facultat de Medicina i Ciències de la Salut)
Stigmatization is a well-documented problem of some diseases. Perceived stigma is common in alcohol-related liver disease and hepatitis C, but little information exists on stigma in patients with non-alcoholic fatty liver disease (NAFLD). [...]
2022 - 10.1371/journal.pone.0265153
PloS one, Vol. 17 (april 2022)
|
|
|
6.
|
|
11 p, 1.9 MB |
Control of Brain State Transitions with a Photoswitchable Muscarinic Agonist
/
Barbero-Castillo, Almudena (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Riefolo, Fabio (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ;
Matera, Carlo (University of Milan) ;
Caldas-Martínez, Sara (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Mateos-Aparicio, Pedro (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Weinert, Julia F. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Garrido-Charles, Aida (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ;
Claro Izaguirre, Enrique (Universitat Autònoma de Barcelona) ;
Sánchez-Vives, María V (Institució Catalana de Recerca i Estudis Avançats) ;
Gorostiza, Pau (Institució Catalana de Recerca i Estudis Avançats)
The ability to control neural activity is essential for research not only in basic neuroscience, as spatiotemporal control of activity is a fundamental experimental tool, but also in clinical neurology for therapeutic brain interventions. [...]
2021 - 10.1002/advs.202005027
Advanced science, Vol. 8 (may 2021)
|
|
|
7.
|
|
18 p, 6.2 MB |
Aortic disease in Marfan syndrome is caused by overactivation of sGC-PRKG signaling by NO
/
de la Fuente-Alonso, Andrea (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Toral, Marta (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Alfayate, Alvaro (Cardiovascular Proteomics Laboratoy (Madrid)) ;
Ruiz-Rodríguez, María Jesús (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Bonzon-Kulichenko, Elena (Cardiovascular Proteomics Laboratoy) ;
Teixido-Tura, Gisela (Hospital Universitari Vall d'Hebron) ;
Martínez-Martínez, Sara (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Méndez-Olivares, María José (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
López-Maderuelo, Dolores (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
González-Valdés, Ileana (Cardiovascular Proteomics Laboratoy (Madrid)) ;
Garcia-Izquierdo, Eusebio (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Mingo, Susana (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Martín, Carlos E. (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Muiño-Mosquera, Laura (Universitair Ziekenhuis Gent) ;
De Backer, Julie (Universitair Ziekenhuis Gent) ;
Nistal, J. Francisco (Instituto de Investigación Sanitaria Valdecilla (Santander, Cantàbria)) ;
Forteza, Alberto (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Evangelista Masip, Arturo (Hospital Universitari Vall d'Hebron) ;
Vázquez, Jesús (Cardiovascular Proteomics Laboratoy (Madrid)) ;
Campanero, Miguel R. (Centro de Biología Molecular Severo Ochoa) ;
Redondo, Juan Miguel (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Universitat Autònoma de Barcelona
Thoracic aortic aneurysm, as occurs in Marfan syndrome, is generally asymptomatic until dissection or rupture, requiring surgical intervention as the only available treatment. Here, we show that nitric oxide (NO) signaling dysregulates actin cytoskeleton dynamics in Marfan Syndrome smooth muscle cells and that NO-donors induce Marfan-like aortopathy in wild-type mice, indicating that a marked increase in NO suffices to induce aortopathy. [...]
2021 - 10.1038/s41467-021-22933-3
Nature communications, Vol. 12 (may 2021)
|
|
|
8.
|
|
10 p, 590.7 KB |
Role of VEGF Polymorphisms in the Susceptibility and Severity of Interstitial Lung Disease
/
Remuzgo-Martínez, Sara (Genetic epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System) ;
Genre, Fernanda (Genetic epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System) ;
Pulito-Cueto, Verónica (Genetic epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System) ;
Atienza-Mateo, Belén (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Mora Cuesta, Víctor Manuel (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Iturbe, David (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Fernández Rozas, Sonia María (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Lera-Gómez, Leticia (Genetic epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System) ;
Alonso Lecue, Pilar (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Ussetti, María Piedad (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Laporta, Rosalía (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Berastegui García, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Solé, Amparo (Hospital Universitari i Politècnic La Fe (València)) ;
Pérez González, Virginia Luz (Hospital Universitario 12 de Octubre (Madrid)) ;
De Pablo Gafas, Alicia (Hospital Universitario 12 de Octubre (Madrid)) ;
Gualillo, Oreste (Instituto de Investigación Sanitaria de Santiago (IDIS)) ;
Cifrián, José Manuel (Universidad de Cantabria) ;
López-Mejías, Raquel (Genetic epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System) ;
Gonzalez-Gay, MA (University of the Witwatersrand) ;
Universitat Autònoma de Barcelona
The search for biomarkers that can help to establish an early diagnosis and prognosis of interstitial lung disease (ILD) is of potential interest. VEGF polymorphisms have been implicated in the development of several lung disorders. [...]
2021 - 10.3390/biomedicines9050458
Biomedicines, Vol. 9 (april 2021)
|
|
|
9.
|
|
13 p, 274.5 KB |
HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels
/
López-Dupla, Miguel (Hospital Universitari Joan XXIII de Tarragona) ;
Maymó-Masip, Elsa (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ;
Martínez, Esteban (Hospital Clínic i Provincial de Barcelona) ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
Leal, Manuel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Peraire, Joaquim (Hospital Universitari Joan XXIII de Tarragona) ;
Viladés, Consuelo (Hospital Universitari Joan XXIII de Tarragona) ;
Veloso, Sergi (Hospital Universitari Joan XXIII de Tarragona) ;
Arnedo, Mireia (Hospital Clínic i Provincial de Barcelona) ;
Ferrando-Martínez, Sara (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Beltrán-Debón, Raúl (Hospital Universitari Joan XXIII de Tarragona. Institut d'Investigació Sanitària Pere Virgili) ;
Alba, Verónica (Hospital Universitari Joan XXIII de Tarragona. Institut d'Investigació Sanitària Pere Virgili) ;
Gatell, Josep Mª (Hospital Clínic i Provincial de Barcelona) ;
Vendrell, Joan (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ;
Vidal, Francesc (Hospital Universitari Joan XXIII de Tarragona) ;
Chacón, Matilde R. (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ;
Universitat Autònoma de Barcelona
Obesity and HIV-1/HAART-associated lipodystrophy syndrome (HALS) share clinical, pathological and mechanistic features. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is a multifunctional cytokine that plays an important role in obesity and related diseases. [...]
2015 - 10.1371/journal.pone.0144789
PloS one, Vol. 10 (december 2015)
|
|
|
10.
|
|
17 p, 4.3 MB |
ATG5 overexpression is neuroprotective and attenuates cytoskeletal and vesicle-trafficking alterations in axotomized motoneurons
/
Leiva-Rodríguez, Tatiana (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Romeo-Guitart, David (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Marmolejo Martínez-Artesero, Sara (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Herrando-Grabulosa, Mireia (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Bosch i Merino, Assumpció (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Forés, Joaquim (Hospital Clínic i Provincial de Barcelona) ;
Casas Louzao, Caty (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia)
Injured neurons should engage endogenous mechanisms of self-protection to limit neurodegeneration. Enhancing efficacy of these mechanisms or correcting dysfunctional pathways may be a successful strategy for inducing neuroprotection. [...]
2018 - 10.1038/s41419-018-0682-y
Cell death and disease, Vol. 9 (may 2018)
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
